Abstract Details

Title PRISM II: An Open-Label Study to Assess the Safety, Tolerability, and Effectiveness of Dextromethorphan 20 mg/Quinidine 10 mg for Treatment of Pseudobulbar Affect Secondary to Dementia, Stroke, or Traumatic Brain Injury: Results from the Alzheimer’s Disease/Dementia Cohort

Topic Aging, Dementia, and Behavioral Neurology

Presentation(s) (-)

Poster/Presentation
Number 109

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Rachelle S. Doody, MD, PhD PRESENTER	Dr. Doody has received personal compensation for serving as an employee of F. Hoffman-LaRoche. Dr. Doody has stock in F. Hoffman-LaRoche.
	No disclosure on file
	No disclosure on file
Paul Shin (Avanir Pharmaceuticals)	No disclosure on file
	No disclosure on file
Charles Yonan, PharmD (Avanir Pharmaceuticals)	No disclosure on file
Joao O. Siffert, MD	No disclosure on file

��ɫ��

��ɫ��

Abstract Details

��ɫ����

��ɫ����

��ɫ��

��ɫ��